EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieKlinische Studie (Phase III)Multizentrische Studie

Letrozole to prevent breast cancer in postmenopausal women with BRCA1/2 mutations (LIBER study)

Pascal Pujol, Lise Roca, Alain Lortholary, Christine Lasset, Louise Crivelli, Pascaline Berthet, Isabelle Tennevet, Thierry Petit, Nathalie Chabbert-Buffet, Paul Gesta, Claire Saule, Jean Chiesa und 12 weitere

European Journal of Cancer · 2025

DOI: 10.1016/j.ejca.2025.116101 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift European Journal of Cancer, 2025. Verfasst von Pascal Pujol und 23 weiteren Autor:innen. Beteiligte Einrichtung: University Hospital of Montpellier - Arnaud De Villeneuve, Montpellier, France. Electronic address: p-pujol@chu-montpellier.fr. Hauptthemen laut MEDLINE: Breast Neoplasms, Letrozole, Aromatase Inhibitors, BRCA2 Protein. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 37 Literaturangaben. Gefördert von: Ministère des Solidarités et de la Santé, Ligue Contre le Cancer.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsLetrozoleAromatase InhibitorsBRCA2 ProteinBRCA1 ProteinHumansFemalePostmenopauseMiddle AgedDouble-Blind MethodAgedAdultGerm-Line MutationQuality of LifeGenes, BRCA2Genetic Predisposition to DiseaseMutationTreatment Outcome

Stichwörter der Autor:innen

Aromatase inhibitorsBRCA mutationBreast cancerChemopreventionLetrozole

Substanzen

LetrozoleAromatase InhibitorsBRCA2 ProteinBRCA1 protein, humanBRCA2 protein, humanBRCA1 Protein

Autor:innen und Institutionen

  • University Hospital of Montpellier - Arnaud De Villeneuve, Montpellier, France. Electronic address: p-pujol@chu-montpellier.fr.
  • Unité de biométrie, Institut de Cancérologie de Montpellier, Montpellier, France.
  • Hôpital privé du confluent - Centre Catherine De Sienne, Nantes, France.
  • Centre Léon Bérard, Lyon, France.
  • Centre Eugène Marquis, Rennes, France.
  • Centre François Baclesse, Caen, France.

Förderung

  • Ministère des Solidarités et de la Santé
  • Ligue Contre le Cancer

Zitieren

APA

Pujol, P., Roca, L., Lortholary, A., Lasset, C., Crivelli, L., Berthet, P., Tennevet, I., Petit, T., Chabbert-Buffet, N., Gesta, P., Saule, C., Chiesa, J., Nguyen, T. D., Mailliez, A., Callet, N. A., Noguès, C., Dreyfus, H., Delnatte, C., Prieur, F., …, & Delaloge, S. (2025). Letrozole to prevent breast cancer in postmenopausal women with BRCA1/2 mutations (LIBER study). European Journal of Cancer. https://doi.org/10.1016/j.ejca.2025.116101

Vancouver

Pujol P, Roca L, Lortholary A, Lasset C, Crivelli L, Berthet P, et al. Letrozole to prevent breast cancer in postmenopausal women with BRCA1/2 mutations (LIBER study). European Journal of Cancer. 2025. doi:10.1016/j.ejca.2025.116101

BibTeX
@article{Pujol2025,
  author = {Pujol, Pascal and Roca, Lise and Lortholary, Alain and Lasset, Christine and Crivelli, Louise and Berthet, Pascaline and Tennevet, Isabelle and Petit, Thierry and Chabbert-Buffet, Nathalie and Gesta, Paul and Saule, Claire and Chiesa, Jean and Nguyen, Tan Dat and Mailliez, Audrey and Callet, Nasrine Afdjei and Noguès, Catherine and Dreyfus, Hélène and Delnatte, Capucine and Prieur, Fabienne and Gladieff, Laurence and Ingster, Olivier and Galibert, Virginie and Lemonnier, Jérôme and Delaloge, Suzette},
  title = {Letrozole to prevent breast cancer in postmenopausal women with BRCA1/2 mutations (LIBER study)},
  journal = {European Journal of Cancer},
  year = {2025},
  doi = {10.1016/j.ejca.2025.116101}
}
Kostenlos starten →